Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487513 · ClinicalTrials.gov registry record
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 40
- Enrollment target
NCT00487513 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 40 participants.
The verdict
NCT00487513 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
In order to learn more about follicular lymphoma and anti-cancer vaccines, we are collecting samples from people with this diagnosis. We then hope to make a vaccine from this tissue to help the immune system destroy cancer cells. We plan on keeping samples in the tissue bank indefinitely.
Interventions
- PROCEDURE Procurement of Follicular B Cell Lymphoma Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-06 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487513
The ClinicalTrials.gov registry entry for NCT00487513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procurement of Follicular B Cell Lymphoma Cells is the first listed.
NCT00487513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487513 about?
NCT00487513 is a clinical study titled "Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials". In order to learn more about follicular lymphoma and anti-cancer vaccines, we are collecting samples from people with this diagnosis. We then hope to make a vaccine from this tissue to help the immune system destroy cancer cells. We plan on keeping samples in the tissue bank indefinitely.
What is the current status of trial NCT00487513?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT00487513?
The interventions under investigation include: Procurement of Follicular B Cell Lymphoma Cells (PROCEDURE).
Who is sponsoring clinical trial NCT00487513?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.